LLY Stock Jumps as Q3 Earnings Beat Estimates, 2026 Sales View Raised - Zacks Investment Research
LLY Stock Jumps as Q3 Earnings Beat Estimates, 2026 Sales View Raised - Zacks Investment Research(摘要待生成)
Lilly, Exxon Mobil and Chevron Report Strong Third-Quarter Results
According to the report, Lilly posted third-quarter 2026 revenue of $24.397 billion, up 39% year over year. [[fact-rkd6lvapn]] Mounjaro and Zepbound generated global revenue of $10.723 billion and $5.352 billion, respectively. [[fact-yatcs2vaw]] Lilly raised its full-year revenue guidance to $91 billion–$92 billion. [[fact-efmm0o6o3]] Lilly shares closed at $1,417.54 and reached another record high. [[fact-54geohg2s]] Exxon Mobil reported third-quarter profit of $15.4 billion, up 104% year over year. [[fact-1shc5qjxe]] Chevron reported third-quarter profit of $9.9 billion, nearly three times the year-earlier level. [[fact-a29ahqd2x]]
Eli Lilly Beats Expectations and Raises Full-Year Revenue Guidance Again
U.S. innovative drug stocks continued to strengthen. [[fact-rno4fvvve]] Technology stocks declined. [[fact-rno4fvvve]] Eli Lilly's performance exceeded expectations. [[fact-tdinoxb2q]] Eli Lilly raised its full-year revenue guidance for the third time this year. [[fact-r17ax9u0q]] Domestic innovative drugs have also entered a stage of earnings validation. [[fact-h2gy2l7b9]]
S&P 500, Nasdaq End Third Straight Week Lower As Investors Move Away From Tech, AI — AMZN, INTC, LLY, RBLX In Focus - Yahoo Finance
S&P 500, Nasdaq End Third Straight Week Lower As Investors Move Away From Tech, AI — AMZN, INTC, LLY, RBLX In Focus - Yahoo Finance(摘要待生成)
Eli Lilly Beats Q3 Revenue and Adjusted EPS Expectations
Eli Lilly reported third-quarter revenue of $24.397 billion, up 39% year over year and above the analyst average forecast of $22.61 billion. [[fact:fact-5yddqwl5h]] The company reported adjusted earnings per share of $7.48, above expectations of $6.26. [[fact:fact-q10vd54uh]] Mounjaro global third-quarter sales rose 65% year over year to $10.723 billion. [[fact:fact-h7okpic4j]] Zepbound third-quarter sales were $5.352 billion, up 49% year over year. [[fact:fact-etwbp92xe]] Foundayo third-quarter sales were $184 million, below analysts’ approximately $229 million expectation. [[fact:fact-p6jjn7eel]]
Eli Lilly (LLY) Q3 2026 Earnings Call Transcript
Eli Lilly raised its 2026 full-year revenue guidance from $85 billion–$87 billion to $91 billion–$92 billion. [[fact-fwf79asg0]] The company expects approximately $2 billion of 2026 revenue to come from one-time items that are not expected to recur. [[fact-fwf79asg0]] Lilly lowered its full-year adjusted EPS guidance from $35.50–$36.50 to $35–$36. [[fact-xkhnwf85j]] The company raised its performance margin guidance from 49%–50.5% to 52%–52.5%. [[fact-jr5ldppr6]] Lilly reported third-quarter revenue growth of 39% year over year. [[fact-pzot6mh64]]
Lilly (LLY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Lilly (LLY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance(摘要待生成)
Lilly CEO Says AI Curing Cancer Within a Decade Is Unlikely
Eli Lilly CEO Dave Ricks described the vision of AI curing cancer within ten years as appealing but unlikely. [[fact-gbltxitt6]] Ricks said major gaps remain in human understanding of biology. [[fact-5tpghqs9h]] He said obtaining reliable evidence through randomized human trials remains a key bottleneck in determining R&D timelines. [[fact-lvbeo80m1]] The article states that finding drug candidates faster does not mean proving them safe and effective for patients can happen just as quickly. [[fact-9mh6z7dc2]] Dario Amodei previously said cancer, Alzheimer's disease, heart disease, and mental illness could become a thing of the past in less than ten years. [[fact-la0h3az9y]] Ricks expects AI's progress in the pharmaceutical industry to be steady and gradual. [[fact-9l4oh8x8q]]
Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY - Yahoo Finance
Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY - Yahoo Finance(摘要待生成)
早报丨伊朗坚持要求美国满足七项条件,WTI原油、布油涨近1%;苹果发布新款MacBook Pro,谷歌债务风险指标上升;绩优股礼来夜盘上涨,英特尔、亚马逊绩后下跌;埃克森美孚、雪佛龙美股盘前发财报 _ 东方财富网
早报丨伊朗坚持要求美国满足七项条件,WTI原油、布油涨近1%;苹果发布新款MacBook Pro,谷歌债务风险指标上升;绩优股礼来夜盘上涨,英特尔、亚马逊绩后下跌;埃克森美孚、雪佛龙美股盘前发财报 _ 东方财富网(摘要待生成)
礼来第三季度营收同比增长39%至244亿美元 上调全年营收指引
礼来第三季度营收同比增长39%至244亿美元 上调全年营收指引(摘要待生成)
礼来(LLY.US)又出手!最高15亿美元收购Calytrix,押注罕见血癌疗法
礼来(LLY.US)又出手!最高15亿美元收购Calytrix,押注罕见血癌疗法(摘要待生成)
礼来拟以最高15亿美元现金收购Calytrix Bio
礼来拟以最高15亿美元现金收购Calytrix Bio(摘要待生成)
礼来:三款肿瘤领域创新药物新增适应症纳入国家医保目录
礼来:三款肿瘤领域创新药物新增适应症纳入国家医保目录(摘要待生成)
口服GLP-1减重药国内首获批,礼来抢先卡位千亿赛道
口服GLP-1减重药国内首获批,礼来抢先卡位千亿赛道(摘要待生成)
礼来公布Taltz与Zepbound联合治疗新数据 银屑病关节炎患者疾病活动度及代谢指标改善
礼来公布Taltz与Zepbound联合治疗新数据 银屑病关节炎患者疾病活动度及代谢指标改善(摘要待生成)